| Trial ID: | L0735 |
| Source ID: | NCT06428825
|
| Associated Drug: |
Bay3283142
|
| Title: |
A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Arterial Hypertension
|
| Interventions: |
DRUG: BAY3283142|DRUG: Placebo to BAY3283142
|
| Outcome Measures: |
Primary: Number of participants with treatment-emergent adverse events per treatment arm (pooled placebo analysis), up to 7 days after last intake of study intervention |
|
| Sponsor/Collaborators: |
Sponsor: Bayer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
72
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2024-08-07
|
| Completion Date: |
2025-11-05
|
| Results First Posted: |
|
| Last Update Posted: |
2025-04-15
|
| Locations: |
Clinical Research Services | Clinical Research Services Mannheim - Phase one unit, Mannheim, Baden-Württemberg, 68167, Germany|CRS Clinical Research Services Berlin GmbH, Berlin, 13627, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT06428825
|
